StockNews.com lowered shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a research note published on Wednesday. A number of other equities analysts have also weighed in on the company. Oppenheimer reiterated an outperform rating and set a $10.00 target price on shares of Aldeyra Therapeutics in […]
StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a research report released on Tuesday morning. Several other equities analysts have also commented on the company. HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of Aldeyra Therapeutics in a […]
Aldeyra Therapeutics (ALDX) Outperform Rating Reaffirmed at Oppenheimer theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Aldeyra Therapeutics (NASDAQ:ALDX) Earns Buy Rating from HC Wainwright wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) major shareholder Perceptive Advisors Llc acquired 37,712 shares of the firm’s stock in a transaction that occurred on Friday, April 5th. The shares were bought at an average price of $4.74 per share, with a total value of $178,754.88. Following the acquisition, the insider now directly owns […]